Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

/by

Authors: Javier Fernández‐Ruiz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger Pertwee, et al
British Journal of Clinical Pharmacology, February 2013
—
Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders exerted through molecular mechanisms that are yet to be completely identified. CBD acts in some experimental models as an anti-inflammatory, anticonvulsant, anti-oxidant, anti-emetic, an…

Read more

Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results.

/by

Authors: Sunil Aggarwal
Clinical Journal of Pain, February 2013
—
OBJECTIVES: This article attempts to cover pragmatic clinical considerations involved in the use of cannabinergic medicines in pain practice, including geographical and historical considerations, pharmacokinetics, pharmacodynamics, adverse effects, drug interactions, indicatio…

Read more